Stocks
ANI Pharmaceuticals (ANIP) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.03 | 6.12 | -111.1 | 4.96 | 0.59 | 7.51 | |||
| Changes by years, y/y, % | -1% | +201% | -1 916% | -104% | -88% | -22.0% | |||
ANI Pharmaceuticals. Debt/EBITDA
ANI Pharmaceuticals. Debt/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 0.89 | 0.86 | 0.64 | 0.58 | 7.51 | 7.51 | ||
| Changes by years, y/y, % | -114% | -88% | -81% | -58% | +748% | |||
| Changes by quarters, q/q, % | -37% | -3% | -26% | -9% | +1 187% | |||
